A retinol glycolic acid body butter sold in the United States is regulated as a cosmetic under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), provided you make only cosmetic claims — improving skin texture, reducing the appearance of uneven tone, smoothing rough patches — and not drug claims like treating a skin disease or condition.
MoCRA introduced four key new requirements that were not in effect before 2023. First, facility registration: every facility that manufactures or processes cosmetics for U.S. distribution must register with the FDA by December 29, 2023 (for facilities already in operation) or within 60 days of beginning operations. Confirm your contract manufacturer is registered. Second, product listing: each cosmetic product must be listed with the FDA including its facility association and full ingredient list. This is the brand owner's (your) obligation, not the manufacturer's. Third, serious adverse event reporting: if a consumer reports a serious adverse event (hospitalization, disfigurement, etc.) linked to your product, you must report it to the FDA within 15 business days. Fourth, substantiation of safety: you must have data to support that your product is safe as marketed. Stability data, PET results, and HRIPT (human repeat insult patch test) data collectively form this file.
Labeling requirements under 21 CFR Part 701 require: product identity (what it is), net weight in U.S. and metric units, responsible party name and address, and a full INCI ingredient list in descending order of predominance. For AHA products, the FDA's 2005 guidance recommends a UV advisory statement on the label.
For Prop 65 (California Safe Drinking Water and Toxic Enforcement Act), retinol (vitamin A) at high oral doses is a listed reproductive toxicant, but topical cosmetic use at label-specified amounts is generally not required to carry a Prop 65 warning — confirm with a regulatory attorney if your retinol % is at the high end.
For EU export, EU Cosmetics Regulation 1223/2009 applies, requiring a CPSR, a Responsible Person established in the EU, a Product Information File, and compliance with the EU's annexes on prohibited and restricted substances. The SCCS 2022 opinion on retinol (capping body products at 0.3%) must be reflected in your safety assessment.
Keep all documentation — stability data, safety assessments, manufacturing records, and INCI support documents — organized before you launch. Regulatory readiness is as important as formula quality for a product in this active-ingredient category.
Ingredients in this answer: Glycolic Acid · Retinol
Read the full guide on Private Label Retinol Glycolic Acid Body Butter – Low MOQ →